To further investigate the implications of overexpression of Aurora A and Bcl-xL in TNBC breast cancer patients, we assessed the correlation between AURKA and BCL2L1 mRNA expression and clinical outcomes using the web-based tool KM plotter. The gene discussed is AURKA; the disease is breast cancer.